NCM · Financial Statements

Pulmatrix, Inc. (PULM) Revenue, Earnings & Financial Statements

$1.38 NCM: PULM Market Cap $5.04M

Data as of Nov 17, 2026 (intraday, delayed) · Statements through the quarter ended Jun 2026 · Source: Financial Modeling Prep (methodology)

Pulmatrix, Inc. most recently reported annual revenue of $0, a net loss of $5.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Pulmatrix, Inc.: Revenue fell from $1.0M in 2016 to $0 in 2025, a change of -100.0% over 9 years; net profit was positive in 0 of 10 reported years; operating margin moved from -2978.0% to -125.1%, a shift of +2852.9 percentage points; the most recent year shows a net loss of $5.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$1.0M$0$0$8.0M$13.0M$5.0M$6.0M$7.0M$8.0M$0
Operating Expenses$26.0M$18.0M$21.0M$29.0M$22.0M$25.0M$25.0M$22.0M$18.0M$5.0M
Operating Profit−$25.0M−$17.0M−$20.0M−$21.0M−$10.0M−$20.0M−$19.0M−$15.0M−$10.0M−$5.0M
Operating Margin-2978.0%-5216.4%-13333.3%-261.6%-78.1%-390.1%-312.1%-202.0%-125.1%—
Other Income−$6.0M−$1.0M$0$0−$9.0M$0$0$1.0M$0$0
Interest$1.0M$1.0M$0$0$0$0$0$0$0$0
Depreciation$0$0$0$1.0M$1.0M$1.0M$2.0M$1.0M$0$0
Profit Before Tax−$31.0M−$18.0M−$21.0M−$21.0M−$19.0M−$20.0M−$19.0M−$14.0M−$10.0M−$5.0M
Tax rate (%)9.6%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$28.0M−$18.0M−$21.0M−$21.0M−$19.0M−$20.0M−$19.0M−$14.0M−$10.0M−$5.0M
EPS−$375.87−$186.42−$99.67−$24.37−$19.83−$8.63−$5.43−$3.87−$2.62−$1.41

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$2.0M$2.0M$6.0M$2.0M$0$0$0$0$0$0$0$0
Operating Expenses$6.0M$4.0M$5.0M$7.0M$3.0M$2.0M$2.0M$2.0M$1.0M$1.0M$1.0M$1.0M
Operating Profit−$4.0M−$2.0M$1.0M−$6.0M−$3.0M−$2.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M
Operating Margin-224.7%-101.0%12.7%-380.2%-726.0%-65066.7%——————
Interest$0$0$0$0$0$0$0$0$0$0$0$0
Profit Before Tax−$4.0M−$2.0M$1.0M−$6.0M−$3.0M−$2.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M
Tax rate (%)0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net Profit−$4.0M−$2.0M$1.0M−$6.0M−$3.0M−$2.0M−$2.0M−$2.0M−$1.0M−$1.0M−$1.0M−$1.0M
EPS−$1.03−$0.57$0.23−$1.59−$0.71−$0.54−$0.49−$0.42−$0.24−$0.25−$0.32−$0.29

Over the 10 years reported for Pulmatrix, Inc., borrowings decreased from $6.0M in 2016 to $0 in 2025, cash stood at $4.0M in the latest year, shareholders' equity was $0.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$17.0M$16.0M$15.0M$36.0M$38.0M$59.0M$41.0M$34.0M$10.0M$4.0M
Current Assets$5.0M$4.0M$3.0M$31.0M$33.0M$55.0M$38.0M$21.0M$10.0M$4.0M
Cash$4.0M$4.0M$3.0M$23.0M$32.0M$54.0M$36.0M$19.0M$10.0M$4.0M
Inventory$0$0$0$0$1.0M$0$0$0$0$0
Receivables$0$0$0$7.0M$0$0$1.0M$1.0M$0$0
Fixed Assets$1.0M$1.0M$0$1.0M$2.0M$2.0M$1.0M$11.0M$0$0
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$2.0M$1.0M$1.0M$0$0
Other Assets$11.0M$11.0M$11.0M$4.0M$4.0M$0$0$0$0$0
Total Liabilities$8.0M$6.0M$3.0M$25.0M$15.0M$11.0M$10.0M$16.0M$1.0M$0
Current Liabilities$5.0M$6.0M$3.0M$17.0M$8.0M$4.0M$5.0M$4.0M$1.0M$0
Borrowings$6.0M$3.0M$0$1.0M$2.0M$2.0M$1.0M$9.0M$0$0
Other Liabilities$2.0M$3.0M$3.0M$24.0M$13.0M$9.0M$9.0M$7.0M$1.0M$0
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$9.0M$10.0M$12.0M$11.0M$23.0M$47.0M$31.0M$18.0M$9.0M$4.0M

For Pulmatrix, Inc., operating cash flow was positive in 1 of 10 reported years; free cash flow in the latest year was negative at $5.0M; free cash flow was positive in 1 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow−$13.0M−$14.0M−$17.0M$3.0M−$12.0M−$20.0M−$19.0M−$16.0M−$11.0M−$5.0M
Investing Cash Flow−$1.0M$0$0$0−$1.0M$0$0−$1.0M−$1.0M$0
Financing Cash Flow$0$0$0$0$14.0M$3.0M$0$0$0$0
Net Cash Flow−$15.0M−$1.0M−$1.0M$21.0M$8.0M$24.0M−$18.0M−$17.0M−$11.0M−$5.0M
Free Cash Flow−$14.0M−$15.0M−$17.0M$3.0M−$13.0M−$20.0M−$19.0M−$17.0M−$11.0M−$5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-0.67
FCF Yield-80.49%
Quick Ratio4.70
Interest Coverage—
Return 1Y-73.63%
Return 3Y-29.12%
Return 5Y-92.12%

Pulmatrix, Inc. (PULM) financials — frequently asked questions

What is Pulmatrix, Inc.'s annual revenue?

Pulmatrix, Inc. (PULM) reported annual revenue of $0 in its most recent fiscal year.

What is Pulmatrix, Inc.'s net profit?

Pulmatrix, Inc. (PULM) reported a net loss of $5.0M in its most recent fiscal year.

What is PULM EV/EBITDA?

Pulmatrix, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.67. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.

Revenue and earnings of other Biotechnology stocks

VRTX revenue $12.1BREGN revenue $14.3BMRNA revenue $1.9BRVMD financialsROIV revenue $8.0MINSM revenue $606.0MUTHR revenue $3.2BINCY revenue $5.1BALNY revenue $3.7BASND revenue $692.0MAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksAll stock screens
PULM Overview PULM Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.